EUVIMEDEUVIMED entdecken
Crossref

Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients

Aschariya Wipattanakitcharoen, Kullaya Takkavatakarn, Suwasin Udomkarnjananun, Paweena Susantitaphong, Jeerath Phannajit

Transplantation Proceedings · 2026-07 · 58 (6) · 968-972

DOI: 10.1016/j.transproceed.2026.05.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2026-07. Verfasst von Aschariya Wipattanakitcharoen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red …. Hauptthemen laut MEDLINE: Tacrolimus, Cinacalcet, Kidney Transplantation, Calcium. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Chulalongkorn University Faculty of Medicine, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypercalcemia with persistent hyperparathyroidism after kidney transplantation is an important risk of cardiovascular disease and allograft dysfunction in kidney transplant recipients (KTRs). Cinacalcet, a calcium-sensing receptor agonist, is commonly used in chronic hemodialysis recipients with secondary hyperparathyroidism; however, its effect and safety in kidney transplant recipients are not established. METHODS: A prospective cohort study was conducted in KTRs with persistent hyperparathyroidism (intact parathyroid hormone [iPTH] >65 pg/mL) for at least 1 year post-transplantation. Participants received cinacalcet 25 mg/day for 3 months. Primary outcomes were changes in serum calcium, serum phosphate, and iPTH concentrations; the secondary outcome was the effect on tacrolimus trough level. RESULTS: Thirty KTRs (mean age, 46.5 years; median time since transplantation, 3 years; mean serum creatinine, 1.5 ± 0.4 mg/dL, mean estimated glomerular filtration rate, 55.4 ± 14.6 mL/min/1.73 m2) completed the study. Administration of cinacalcet significantly reduced serum calcium levels (mean, 9.2 ± 0.7 mg/dL vs 10.1 ± 0.6 mg/dL; P < .001) and increased serum phosphate levels (mean, 3.0 ± 0.6 mg/dL vs 2.7 ± 0.5 mg/dL; P = .006). iPTH levels showed no significant change (median, 178.3 pg/mL vs 176.2 pg/mL; P = .35). Tacrolimus trough levels remained stable (mean, 5.7 ± 1.3 vs 5.9 ± 2.8 ng/mL; P = .68). CONCLUSION: Cinacalcet use can normalize serum calcium levels and maintain tacrolimus levels in KTRs with persistent hyperparathyroidism. However, long-term data, especially for cardiovascular outcomes, merit further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusCinacalcetKidney TransplantationCalciumImmunosuppressive AgentsCalcimimetic AgentsHumansMiddle AgedFemaleProspective StudiesMaleParathyroid HormoneAdultPhosphates

Substanzen

TacrolimusCinacalcetCalciumImmunosuppressive AgentsParathyroid HormonePhosphatesCalcimimetic Agents

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
  • Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand; Center for Excellence of Metabolic B…
  • Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand; Center of Excellence in Renal Immuno…

Förderung

  • Chulalongkorn University Faculty of Medicine
  • Chulalongkorn University

Zitieren

APA

Wipattanakitcharoen, A., Takkavatakarn, K., Udomkarnjananun, S., Susantitaphong, P., & Phannajit, J. (2026). Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients. Transplantation Proceedings, 58(6), 968-972. https://doi.org/10.1016/j.transproceed.2026.05.017

Vancouver

Wipattanakitcharoen A, Takkavatakarn K, Udomkarnjananun S, Susantitaphong P, Phannajit J. Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients. Transplantation Proceedings. 2026;58(6):968-972. doi:10.1016/j.transproceed.2026.05.017

BibTeX
@article{Wipattanakitcharoen2026,
  author = {Wipattanakitcharoen, Aschariya and Takkavatakarn, Kullaya and Udomkarnjananun, Suwasin and Susantitaphong, Paweena and Phannajit, Jeerath},
  title = {Normalized Serum Calcium and Maintained Tacrolimus Levels by Cinacalcet Use in Kidney Transplant Recipients},
  journal = {Transplantation Proceedings},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {968--972},
  doi = {10.1016/j.transproceed.2026.05.017}
}
Kostenlos starten →